IXHL Incannex Healthcare Inc.

Incannex Healthcare Beat Consensus Estimates

Thursday, November 12, 2026 · 12:00 AM ET

Incannex Healthcare (IXHL) reported a loss of $0.15 per share on revenue of $0.00 million for the fiscal first quarter ended September 2026. The consensus estimate was a loss of $0.66 per share. The company beat consensus estimates by 77.27%.

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Earnings Whisper Grade

Power Rating

Reported Earnings

($0.15)

Earnings Whisper^®

—

Consensus Estimate

($0.66)

Earnings Surprise

Earnings Growth

Reported Revenue

—

Revenue Estimate

—

Revenue Surprise

Revenue Growth—

*Reported earnings and revenue figures shown above, and any guidance given, are preliminary and may be updated upon further review.*